| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +500 | +2.9% | $0.000000 | 17,723 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $60,380 | -179 | -1% | $337.32 | 17,544 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +347 | +2% | $0.000000 | 17,891 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $41,828 | -124 | -0.69% | $337.32 | 17,767 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +253 | +1.4% | $0.000000 | 18,020 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $30,696 | -91 | -0.5% | $337.32 | 17,929 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +2% | $0.000000 | 18,290 | 02 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $43,514 | -129 | -0.71% | $337.32 | 18,161 | 02 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +495 | +2.7% | $0.000000 | 18,656 | 03 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $59,173 | -177 | -0.95% | $334.31 | 18,479 | 03 Sep 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -500 | -25% | $0.000000 | 1,503 | 01 Sep 2024 | Bio-Rad A Common Stock | 500 | $0.000000 | Direct | F2, F3 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -347 | -33% | $0.000000 | 694 | 01 Sep 2024 | Bio-Rad A Common Stock | 347 | $0.000000 | Direct | F2, F4 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -253 | -50% | $0.000000 | 254 | 01 Sep 2024 | Bio-Rad A Common Stock | 253 | $0.000000 | Direct | F2, F5 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -361 | -100% | $0.000000 | 0 | 02 Sep 2024 | Bio-Rad A Common Stock | 361 | $0.000000 | Direct | F2, F6 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -495 | -100% | $0.000000 | 0 | 03 Sep 2024 | Bio-Rad A Common Stock | 495 | $0.000000 | Direct | F2, F7 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F4 | On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |